secwatch.observer — SEC 8-K summary
======================================

Issuer:     Envoy Medical, Inc. (COCH)
CIK:        0001840877
Form:       8-K
Filed at:   2025-06-03T23:59:59+00:00
Accession:  0001213900-25-050758
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Stockholders approve amendment to 2023 Equity Incentive Plan, releasing 1.5M restricted shares
--------------------------------------------------------------------------------

- Amendment removes regulatory-milestone restriction on 1,500,000 shares, making them available for issuance under the 2023 Plan.
- Vote: 12,332,451 For, 658,102 Against, 20,782 Abstain, 29,189 Broker Non-Votes; amendment effective immediately.
- Elected directors Janis Smith-Gomez (12,636,087 For) and Chuck Brynelsen (12,307,953 For) to Class II, term until 2028 annual meeting.
- Ratified Grant Thornton LLP as independent auditor for FY2025; approved non-binding advisory vote on named executive officer compensation.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1840877/000121390025050758/0001213900-25-050758-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1840877/000121390025050758/ea0244418-8k_envoy.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-050758

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer